Yantai Valliant Pharmaceutical Co., Ltd.

(Drug, approval number: H20051812)
Product Name: Cilostazol Capsule
Ingredients: The main ingredients is cilostazol.
Description: The contents of the drug are white or off-white powder or granules.
Indications: To improve chronic ulcers, pain, chills, intermittent claudication and other symptoms caused by arteriosclerosis obliterans.
Specifications: 50mg * 10 capsules * 2
Dosage: Orally, 100mg (two capsules)each time , two times a day. Appropriate increase or decrease can be done according to the condition.

Product Features:

1.National medicare Class B drugs.

2.Essential drug in Sichuan, Jiangsu and other provinces.

3.Used as Anticoagulant, it can be taken all throughout the year after heart stent bypass surgery.

4.Designated drug for National Drug Route Management--stroke.

5.The first batch drugs used to treat stable and intermittent claudication during the past 15years in FDA.

6.Can be used for the prevention of alzheimer’s disease and the treatment of diabetic complication.

7.Win the bidding in many provinces. Most suitable for clinical procedures.

 Clinical Application

1.Phosphodiesterase ||| (PDE-|||) inhibitor.

2.Three pharmacological actions:    anti-platelet aggregation

                                            dilate peripheral blood vessels

                                            inhibit vascular smooth muscle cell proliferation

3.The preferred drug for the treatment of peripheral arterial stenosis,peripheral arterial occlusion, aneurysmal dilatation and intermittent claudication.

4.It is used together with aspirin and clopidogrel to treat artery restenosis after heart stent bypass.